Yüklüyor......
Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
Imatinib (Gleevec) is a biological agent that is approved for the treatment of chronic myeloid leukemia (CML) as well as gastrointestinal stromal tumor (GIST). The most frequently seen adverse effects in patients treated with imatinib include superficial edema, muscle cramps, musculoskeletal pain, r...
Kaydedildi:
| Yayımlandı: | Cureus |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cureus
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120973/ https://ncbi.nlm.nih.gov/pubmed/27909636 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.848 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|